UNSPSC 51285406: Cefuracetime

This classification denotes a cephalosporin antibiotic with the molecular formula C17H17N3O8S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) F69EA18270, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-7-((2-furanyl(methylimino)acetyl)amino)-8-oxo-, (6r-(6alpha,7beta(z)))- but more generally known as cefuracetime, which bears US NIH Compound Identifier 9571078.

UNSPSC 51285406 Cefuracetime, a Commodity code, shows minimal recent state and local procurement activity aligned with its nominal scope. The two opportunities tagged under this code—an Illinois Department of Public Health pharmaceutical warehouse piggyback contract for Doxycycline Hyclate and Ciprofloxacin Hydrochloride, and a Seminole County, Florida procurement for Naloxone and drug deactivation systems—do not represent purchases of cefuracetime itself. The code appears to be applied inconsistently or as a catch-all category within pharmaceutical procurement systems rather than driving actual demand for this specific antibiotic. State and local health departments and county health agencies are the issuing bodies present in the recent record, but neither opportunity reflects genuine market activity in the commodity itself.

No open solicitations for cefuracetime under this code are currently active. The Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical contract over three years to Chartwell Rx LLC through the MMCAP Infuse consortium via IFB on August 28, 2026, but the products procured were unrelated to cefuracetime. Seminole County posted an IFB on June 30, 2026, for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, also outside the code's scope. Activity is scattered across Florida and Illinois with no clear geographic concentration. Given the mismatch between the code's definition and recent tagging patterns, vendors should verify code alignment during procurement searches or direct inquiry with issuing health agencies before pursuing opportunities under 51285406.